MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Clinical Profile Of Drug-Induced Movement Disorders In Cipto Mangunkusumo Hospital, Indonesia

V. Sutanto, D. Tunjungsari, A. Tiksnadi (Jakarta, Indonesia)

Meeting: 2023 International Congress

Abstract Number: 605

Keywords: Drug-induced parkinsonism(DIP), Neuroleptic malignant syndrome(NMS), Postural tremors(see Tremors)

Category: Drug-Induced Movement Disorders

Objective: We aimed to portray the clinical spectrum of Drug-induced movement disorders (DIMDs) in Cipto Mangunkusumo Hospital, Jakarta, Indonesia

Background: DIMDs remain a significant burden among specific populations. The onset of DIMDs may varies, from acute to chronic. [1] DIMDs may also be a frequent cause of emergency and life-threatening events. [1] Although DIMDs are commonly encountered, they are still under-reported, especially in developing countries, such as Indonesia.

Method: It is a cross-sectional descriptive study, using our electronic medical record. All DIMD cases over the past three years (2020–2023) were included to the study. The drugs related to DIMDs were classified into Dopamine-receptor blocking agents (DRBA) and non-Dopamine-receptor blocking agents (non-DRBA).

Results: There were 25 subjects. The mean age of our study population was 46,92 ± 22,80 years old, only 36% of subjects were geriatric population (>60 years old). Female subjects were more common (64%). Most of the symptoms were acute onset (76%). DIMDs phenomenology were postural tremor (24%), myoclonus (20%), acute dystonia (20%), neuroleptic malignant syndrome (NMS) (16%), oculogyric crisis (8%), acute dyskinesia (8%), and ataxia (4%). Most of the cases received DRBA (52%) i.e. metoclopramide, haloperidol, risperidon, and aripiprazole. We found that every case of acute dystonia, NMS, and oculogyric crisis were caused by DRBA, whereas most of the tremors and myoclonus were caused by non-DRBA.

Conclusion: We observed DRBA drugs more common causing DIMDs in our study, with metoclopramide as the most suspectible drug. Most of the subjects were female and non-geriatric. The most common DIMDs in DRBA was acute dystonia, whereas in non-DRBA was postural tremor.

References: 1. Duma SR, Fung VS. Drug-induced movement disorders. Aust Prescr. 2019 Apr;42(2):56-61. doi: 10.18773/austprescr.2019.014. Epub 2019 Apr 1. PMID: 31048939; PMCID: PMC6478951.

To cite this abstract in AMA style:

V. Sutanto, D. Tunjungsari, A. Tiksnadi. Clinical Profile Of Drug-Induced Movement Disorders In Cipto Mangunkusumo Hospital, Indonesia [abstract]. Mov Disord. 2023; 38 (suppl 1). https://www.mdsabstracts.org/abstract/clinical-profile-of-drug-induced-movement-disorders-in-cipto-mangunkusumo-hospital-indonesia/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2023 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/clinical-profile-of-drug-induced-movement-disorders-in-cipto-mangunkusumo-hospital-indonesia/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley